Stockerblog.com Parkinson's Stocks
918 views
Rate Now:
average rating: 0.00 / 0 ratings
Created by stockerblog
DESCRIPTION:
Date updated:04-25-2007
Companies researching treatments and cures for this degenerative disorder of the central nervous system that impairs motor skills and speech.
-
TEVA
Teva Pharmaceutic - $52.28
- +0.13%
- $52.37
No Analysis added
-
CEGE
Cege - $0.00
- N/A
- $N/A
No Analysis added
-
NVS
Novartis Ag Ads - $53.24
- +0.83%
- $53.08
No Analysis added
-
ACAD
Acadia Pharmaceut - $1.45
- +4.32%
- $1.43
No Analysis added
-
SNY
Sanofi-aventis Sa - $38.22
- +0.68%
- $38.06
No Analysis added
-
SKYE
N/a - $25.55
- 0.00
- $25.55
No Analysis added
-
VRX
Valeant Pharma In - $33.37
- +1.18%
- $33.03
No Analysis added
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. Charlie Munger
- 5. Calamos Advisors
- show all
- Top Do-It-Yourself Portfolios
- » John Shier
- » Joy
- » tsamanuli Portfolio 1
- » Albo's First Portfolio
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
Jim Cramer's Portfolios of the Week
By Roberto Pedone According to Jim Cramer, investors shouldn’t read too much into Thursday’s market action. He reminded investors that the market has gone up for six...
11.13.09 | 12:48 PM
'Fast Money' Portfolios of the Week
By Roberto Pedone Posted on Nov. 12, 2009 According to CNBC’s “Fast Money” traders, stocks continued to move higher this week, maintaining their strength off the ...
11.12.09 | 11:44 AM
Squeezing the Shorts: Large-Cap ...
By Jonas Elmerraji Posted on Nov. 11, 2009 Recently we put our short-squeeze focus on smaller stocks; this week we’re going large-cap. With higher trading volumes, mo...
11.11.09 | 15:19 PM
Dividend Stocks for the Week
more articles
By Jonas Elmerraji Posted on Nov. 10, 2009 After six straight days of gains, the markets are taking a breather today, which gives us the chance to focus our attention b...
11.10.09 | 15:04 PM
General market Technical Analysi...
11.14.07 | 22:55 PM From author
ZA
The Presidential/Political Thread
01.02.08 | 08:05 AM From author
Dave Cox
Video Charts
10.29.09 | 21:39 PM From author
srea
Wealth distribution by race and ...
more forums
11.23.08 | 18:44 PM From author
Valerie J
Q.
<embed src="http://www.y...
11.14.09 | 11:16 AM Asked by
srea
A. yes...he's making his own videos.
Q.
Steel....playing catch up now. ...
03.24.09 | 11:34 AM Asked by
dgbkr
A. The only one I own : SLX,
too hard pick a winner out all of them
today 's lists
52-Week Highs
Here are some of the biggest stocks that made the 52-week high list on Nov. 13, 2009. more
Analyst Downgrades
Analyst Downgrades for Nov. 13, 2009. Read more here. more
Rising on Unusual Volume
Here are some stocks that moved up on unusual volume on Nov. 13, 2009. more
05/01/2007 17:31 PM CDT Asked by Dark Knight 212
In addition to the companies you listed, I suggest you look at the British biotech firm Amarin (AMRN - Last Trade: 0.68 Change: -0.025). AMRN has ongoing Phase II clinical testing of Miraxion and AMR-101 both for the treatment of Parkinson's Disease.
Amarin recently dropped more than 85 percent on poor results in Phase III tests of Miraxion for Huntington's disease.
After an 85% drop the stock bears watching because they have 4 other drugs in their pipeline that are on track, 29 million dollars cash, no debt and they have 30% insider and 25% institutional ownership.
Management will be providing an update to investors on the progress, plans and timelines for Amarin’s pipeline of products at two upcoming investor conferences. Rodman & Renshaw on May 15th and Banc of America on June 1st. Both of these investor presentations will be webcast so you can listen in. More information about the specifics of the webcasts will be issued in advance of each conference.
Full Disclosure: I own AMRN.